Friday 6 November 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.

Revenue: +58.1%
EPS: +142.2%
Free cash flow: +43.5%

Quarter to September 2026, against a year earlier

94.01 5.67 +6.42%

Follow KNSA

Alert me

Market cap: $6.9B
P/E: 65.9×
Fwd P/E: 67.8×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	8	8	8	8
ROE Full definition →		11.73%	13.74%	14.04%	17.59%
ROA Full definition →		8.78%	10.26%	10.36%	12.92%
ROIC Full definition →		31.44%	42.34%	48.87%	57.65%
Return on Tangible Assets Full definition →		15.13%	16.62%	16.13%	19.54%
Average Days of Receivables Full definition →		8.40	11.24	10.20	11.88
Free Cash Flow per Share Full definition →		1.84	2.15	2.36	2.52
Free Cash Flow Full definition →		136.42	164.23	182.84	197.20
Capital Expenditures Full definition →		(1.57)	(1.63)	(2.13)	(1.64)
Other line items
Cash ROIC Full definition →		13.90%	15.29%	15.49%	15.42%
Accounts Receivable Turnover Full definition →		23.64	23.83	30.36	22.93
Accounts Payable Turnover Full definition →		38.20	6.11	8.01	18.14
Inventory Turnover Full definition →		1.91	1.69	1.44	1.25
Average Days of Payables Full definition →		9.53	110.50	52.91	16.11
Days of Inventory on Hand Full definition →		257.96	331.22	302.55	423.65
Tax Rate Full definition →		(0.34)	(0.31)	(0.29)	(0.25)
Research and Development Expense of Revenue Full definition →		14.29%	13.93%	15.12%	14.35%
Selling, General and Administrative Expense of Revenue Full definition →		28.97%	28.37%	27.46%	26.13%
Share Based Compensation of Revenue Full definition →		5.46%	5.21%	5.00%	4.76%
Operating CF/Net income Full definition →		2.34	2.27	2.29	1.81
Depreciation/Fixed assets Full definition →		0.80	0.84	0.70	0.77
Capex/Depreciation Full definition →		(1.01)	(0.97)	(1.19)	(0.86)
Revenue per Share Full definition →		9.13	9.85	10.84	12.10
Operating CF per Share Full definition →		1.86	2.17	2.38	2.54
Capex per Share Full definition →		(0.02)	(0.02)	(0.03)	(0.02)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly